Publications by authors named "Eric Padron"

100Publications

Retrospective Analysis of the Clinical Use and Benefit of Lenalidomide and Thalidomide in Myelofibrosis.

Clin Lymphoma Myeloma Leuk 2020 Jul 16. Epub 2020 Jul 16.

Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2020.07.006DOI Listing
July 2020

Characterization of myelodysplastic syndromes (MDS) with T-cell large granular lymphocyte proliferations (LGL).

Leukemia 2020 Jun 21. Epub 2020 Jun 21.

Formerly Department of Malignant Hematology, H. Lee Moffitt Cancer center, Tampa, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-020-0928-4DOI Listing
June 2020

Moving towards a uniform risk stratification system in CMML - How far are we?

Best Pract Res Clin Haematol 2020 06 6;33(2):101131. Epub 2019 Dec 6.

Division of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2019.101131DOI Listing
June 2020

Hypomethylating Agent Therapy in Myelodysplastic Syndromes With Chromosome 3 Abnormalities.

Clin Lymphoma Myeloma Leuk 2020 Sep 20;20(9):e597-e605. Epub 2020 Mar 20.

Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2020.03.005DOI Listing
September 2020

SF3B1 Mutations Negatively Predict for Response to Immunosuppressive Therapy in Myelodysplastic Syndromes.

Clin Lymphoma Myeloma Leuk 2020 Jun 10;20(6):400-406.e2. Epub 2020 Jan 10.

Malignant Hematology Department, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2019.12.023DOI Listing
June 2020

Defining Acute Myeloid Leukemia Ontogeny in Older Patients.

Clin Lymphoma Myeloma Leuk 2020 May 9;20(5):312-315. Epub 2019 Nov 9.

Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2019.11.007DOI Listing
May 2020

Decoding Bone Marrow Fibrosis in Myelodysplastic Syndromes.

Clin Lymphoma Myeloma Leuk 2020 May 14;20(5):324-328. Epub 2020 Jan 14.

Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2020.01.003DOI Listing
May 2020

Interrogation of molecular profiles can help in differentiating between MDS and AML with MDS-related changes.

Leuk Lymphoma 2020 Jun 4;61(6):1418-1427. Epub 2020 Feb 4.

Department of Hematopathology and Laboratory Medicine, Moffitt Cancer Center, Tampa, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2020.1719089DOI Listing
June 2020

Treatment of MDS/MPN and the MDS/MPN IWG International Trial: ABNL MARRO.

Curr Hematol Malig Rep 2019 12;14(6):543-549

H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL, 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-019-00553-5DOI Listing
December 2019

Concurrent mutations in other epigenetic modulators portend better prognosis in BCOR-mutated myelodysplastic syndrome.

J Clin Pathol 2020 Apr 26;73(4):209-212. Epub 2019 Nov 26.

Hematopathology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jclinpath-2019-206132DOI Listing
April 2020

Non-canonical transcriptional consequences of BET inhibition in cancer.

Pharmacol Res 2019 12 4;150:104508. Epub 2019 Nov 4.

Moffitt Cancer Center: 12902 USF Magnolia Drive, Tampa, FL 33612, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.phrs.2019.104508DOI Listing
December 2019

Driver mutation-specific clinical and genomic correlates differ between primary and secondary myelofibrosis.

Am J Hematol 2019 12 10;94(12):E314-E317. Epub 2019 Sep 10.

Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25625DOI Listing
December 2019

Relapsed Acute Lymphoblastic Leukemia Presenting as Acute Renal Failure.

Case Rep Nephrol 2019 13;2019:7913027. Epub 2019 May 13.

Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33602, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2019/7913027DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535833PMC
May 2019

A phase 2 trial of the oral smoothened inhibitor glasdegib in refractory myelodysplastic syndromes (MDS).

Leuk Res 2019 06 30;81:56-61. Epub 2019 Mar 30.

Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2019.03.008DOI Listing
June 2019

TP53 and therapy-related myeloid neoplasms.

Best Pract Res Clin Haematol 2019 03 19;32(1):98-103. Epub 2019 Feb 19.

Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2019.02.009DOI Listing
March 2019

Off-target based drug repurposing opportunities for tivantinib in acute myeloid leukemia.

Sci Rep 2019 01 24;9(1):606. Epub 2019 Jan 24.

Department of Drug Discovery, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, 33612, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-018-37174-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345777PMC
January 2019

Current Management and Recent Advances in the Treatment of Chronic Myelomonocytic Leukemia.

Curr Treat Options Oncol 2018 10 27;19(12):67. Epub 2018 Oct 27.

Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, SRB 2nd Floor, 12902 USF Magnolia Drive, Tampa, FL, 33612, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11864-018-0581-6
Publisher Site
http://dx.doi.org/10.1007/s11864-018-0581-6DOI Listing
October 2018

OMIP-049: Analysis of Human Myelopoiesis and Myeloid Neoplasms.

Cytometry A 2018 10;93(10):982-986

Departments of Immunology, H. Lee Moffitt Cancer Center, Tampa, Florida.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cyto.a.23598
Publisher Site
http://dx.doi.org/10.1002/cyto.a.23598DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484443PMC
October 2018

Association of EZH2 protein expression by immunohistochemistry in myelodysplasia related neoplasms with mutation status, cytogenetics and clinical outcomes.

Br J Haematol 2019 02 23;184(3):450-455. Epub 2018 Jan 23.

Departments of Hematopathology and Clinical Medicine, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15099DOI Listing
February 2019

Between a rux and a hard place: evaluating salvage treatment and outcomes in myelofibrosis after ruxolitinib discontinuation.

Ann Hematol 2018 Mar 30;97(3):435-441. Epub 2017 Nov 30.

Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL, 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-017-3194-4DOI Listing
March 2018

ASXL1 frameshift mutations drive inferior outcomes in CMML without negative impact in MDS.

Blood Cancer J 2017 11 27;7(12):633. Epub 2017 Nov 27.

Hematopathology and Laboratory Medicine Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 36612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41408-017-0004-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802523PMC
November 2017

The prognostic value of circulating myeloblasts in patients with myelodysplastic syndromes.

Ann Hematol 2018 Feb 22;97(2):247-254. Epub 2017 Nov 22.

Department of Malignant Hematology, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00277-017-3186-4
Publisher Site
http://dx.doi.org/10.1007/s00277-017-3186-4DOI Listing
February 2018

Chipping in on clonal hematopoiesis.

Oncotarget 2017 Oct 4;8(49):84637-84638. Epub 2017 Oct 4.

Eric Padron: Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.21472DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689560PMC
October 2017

A Phase II Study of CLAG Regimen Combined With Imatinib Mesylate for Relapsed or Refractory Acute Myeloid Leukemia.

Clin Lymphoma Myeloma Leuk 2017 Dec 19;17(12):902-907. Epub 2017 Sep 19.

Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2017.09.007DOI Listing
December 2017

The Treatment Landscape of Myelofibrosis Before and After Ruxolitinib Approval.

Clin Lymphoma Myeloma Leuk 2017 Dec 5;17(12):e45-e53. Epub 2017 Aug 5.

Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2017.08.002DOI Listing
December 2017

Myelodysplasia in younger adults: outlier or unique molecular entity?

Haematologica 2017 06;102(6):967-968

Malignant Hematology Department, H. Lee Moffitt Cancer Center, Tampa, FL, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2017.165993DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451326PMC
June 2017

Detection of Novel t(12;17)(p12;p13) in Relapsed Refractory Acute Myeloid Leukemia by Anchored Multiplex PCR(AMP)-based Next-Generation Sequencing.

Appl Immunohistochem Mol Morphol 2019 03;27(3):e28-e31

Department of Hematopathology and Laboratory Medicine, Moffitt Cancer Center, Tampa, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAI.0000000000000477DOI Listing
March 2019

Evidence for Selective Benefit of Sequential Treatment With Hypomethylating Agents in Patients With Myelodysplastic Syndrome.

Clin Lymphoma Myeloma Leuk 2017 04 10;17(4):211-214. Epub 2017 Jan 10.

Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2016.10.003DOI Listing
April 2017

Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee Experience.

Oncologist 2017 02 8;22(2):144-151. Epub 2017 Feb 8.

DeBartolo Family Personalized Medicine Institute, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2016-0195DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330702PMC
February 2017

Clinical management of myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes.

Cancer Biol Med 2016 Sep;13(3):360-372

Malignant Hematology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.20892/j.issn.2095-3941.2016.0043DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069836PMC
September 2016

Integrating Genomics in Myelodysplastic Syndrome to Predict Outcomes After Allogeneic Hematopoietic Cell Transplantation.

Clin Lymphoma Myeloma Leuk 2017 01 16;17(1):7-13. Epub 2016 Sep 16.

Department of Blood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL; Department of Oncologic Sciences, University of South Florida Morsani College of Medicine, Tampa, FL. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2016.09.005DOI Listing
January 2017

When clinical heterogeneity exceeds genetic heterogeneity: thinking outside the genomic box in chronic myelomonocytic leukemia.

Blood 2016 11 5;128(20):2381-2387. Epub 2016 Oct 5.

Malignant Hematology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-07-692988DOI Listing
November 2016

An Exercise in Extrapolation: Clinical Management of Atypical CML, MDS/MPN-Unclassifiable, and MDS/MPN-RS-T.

Curr Hematol Malig Rep 2016 12;11(6):425-433

H. Lee Moffitt Cancer Center and Research Institute, Malignant Hematology, Tampa, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-016-0350-1DOI Listing
December 2016

Eltrombopag Use in Patients With Chronic Myelomonocytic Leukemia (CMML): A Cautionary Tale.

Clin Lymphoma Myeloma Leuk 2016 08;16 Suppl:S64-6

Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2016.02.009DOI Listing
August 2016

Immunosuppressive Therapy: Exploring an Underutilized Treatment Option for Myelodysplastic Syndrome.

Clin Lymphoma Myeloma Leuk 2016 08;16 Suppl:S44-8

H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2016.02.017DOI Listing
August 2016

Integrating mutation variant allele frequency into clinical practice in myeloid malignancies.

Hematol Oncol Stem Cell Ther 2016 Sep 11;9(3):89-95. Epub 2016 May 11.

Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hemonc.2016.04.003DOI Listing
September 2016

Clinical prognostic factors and outcomes of essential thrombocythemia when transformed to myelodysplastic syndromes and acute myeloid leukemia.

Leuk Res 2016 Mar 2;42:52-8. Epub 2016 Feb 2.

Department of Hematopathology and Laboratory Medicine, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2016.01.015DOI Listing
March 2016

Autoimmune diseases and myelodysplastic syndromes.

Am J Hematol 2016 May 4;91(5):E280-3. Epub 2016 Apr 4.

Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24333DOI Listing
May 2016

Detection of a PDGFRB fusion in refractory CMML without eosinophilia: A case for broad spectrum tumor profiling.

Leuk Res Rep 2015 24;4(2):70-1. Epub 2015 Sep 24.

Department of Hematologic Malignancies and Immunology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lrr.2015.07.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4672079PMC
December 2015

Surveying the landscape of MDS/MPN research: overlap among the overlap syndromes?

Authors:
Eric Padron

Hematology Am Soc Hematol Educ Program 2015 ;2015:349-54

Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2015.1.349DOI Listing
October 2016

Lenalidomide Treatment for Lower Risk Nondeletion 5q Myelodysplastic Syndromes Patients Yields Higher Response Rates When Used Before Azacitidine.

Clin Lymphoma Myeloma Leuk 2015 Nov 2;15(11):705-10. Epub 2015 Sep 2.

Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2015.08.083DOI Listing
November 2015

Validation of the Lower-Risk MD Anderson Prognostic Scoring System for Patients With Myelodysplastic Syndrome.

Clin Lymphoma Myeloma Leuk 2015 Jun;15 Suppl:S60-3

H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2015.03.011DOI Listing
June 2015

Transformation of the Clinical Management of CMML Patients Through In-Depth Molecular Characterization.

Clin Lymphoma Myeloma Leuk 2015 Jun;15 Suppl:S50-5

Malignant Hematology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2015.03.005DOI Listing
June 2015

Myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms: an update on risk stratification, molecular genetics, and therapeutic approaches including allogeneic hematopoietic stem cell transplantation.

Am Soc Clin Oncol Educ Book 2015 :e398-412

From the Section of Hematology/Oncology, and the Comprehensive Cancer Center, The University of Chicago, Chicago, IL; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy; Moffitt Cancer Center, Tampa, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2015.35.e398DOI Listing
February 2016

Cutting the cord from myelodysplastic syndromes: chronic myelomonocytic leukemia-specific biology and management strategies.

Curr Opin Hematol 2015 Mar;22(2):163-70

aH. Lee Moffitt Cancer Center, Tampa, Florida bDana-Farber Cancer Institute, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOH.0000000000000112DOI Listing
March 2015

Current state of prognostication and risk stratification in myelodysplastic syndromes.

Curr Opin Hematol 2015 Mar;22(2):146-54

aSection of Hematology, Department of Internal Medicine, Yale University, New Haven, Connecticut bDepartment of Malignant Hematology, H Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOH.0000000000000110DOI Listing
March 2015